Gilead Sciences

Open: 73.25 Close: 73.55 Change: 0.3

The best way to get information about Gilead Sciences Stock: Use an AI.

This document will help you to evaluate Gilead Sciences without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Gilead Sciences are: Sciences, Gilead, Inc, GILD, Buy, share, stock, …

Concept Map

Semantic Network

Stock Summary

Gilead Sciences, Inc. discovers, develops, and commercializes medicines in the areas of unmet medical need. The company provides Biktarvy, Genvoya, Descovy, Descogna, Odefsey,.

Today's Summary

Gilead Sciences has paused enrolment in the magrolimab solid tumour trials, with the FDA requesting a partial clinical hold on these studies. Gileades develops and markets therapies to treat life-threatening infectious diseases.

Today's News

Gilead Sciences Inc. per Employee $1.595M P/E Ratio 16.32 EPS $4.51 Yield 4.19% Dividend $0.77 Ex-Dividend Date Mar 14, 2024 Short Interest 15.66M 01/31/24. Gilead Sciences has paused enrolment in the magrolimab solid tumour trials, with the FDA requesting a partial clinical hold on these studies. FDA considers a T cell malignancy risk to be applicable to all commercial CAR-T therapies. Gilead Sciences, Inc. (GILD) Price Target $86.38 (17.44% upside) Analyst Consensus: Buy Stock Forecasts. CymaBay Therapeutics (CBAY) soared to an all-time high Monday. Daniel ODay of Gilead Sciences Becomes New Chair of PhRMA Board. Ted Love, MD, Joins Gileade Sciences Board of Directors. Gileades develops and markets therapies to treat life-threatening infectious diseases. gilead sciences stock price today (nasdaq: gild) quote, market cap, chart, chart | wallstreetzen.com. Gilead Sciences Inc. had 17,000 employees on December 31, 2022. The employee data is based on information from people who have self-reported past or current employments. The data presented on this page does not represent the view of Gileads.com. Gilead Sciences (GILD) reported earnings of $1.72 per share, missing the Zacks Consensus Estimate of $ 1.76 per share. The next GileAD Sciences ( GILD) dividend date is projected to be March 14, 2024. Gilead Sciences is a public company that is publicly traded. Over the next 52 weeks, the company has on average historically risen by 23.6%. Gilead Sciences Inc. stock underperforms thursday when compared to competitors - marketwatch.com. GILD +1.06% SPX +0.03% DJIA + 0.16% JNJ - 0.87% PFE +087% ABT +037% Gilead Sciences stock rose 1,550% between February 2004 and August 2015, when it traded near all-time highs. Shareholders pay a quarterly dividend of $0.77 per share translating to a forward yield of 428%. Gilead Sciences Inc. (GILD-Q) Rating: 4 out of 5 Bullish - Buy Buy Signals / Votes : 3 Neutral - Hold Signals - Sell Signals : 1 Bearish - Sell Signal. Buy, Sell or Hold: Gileads Inc. $60 share price a good time to buy.

Stock Profile

"Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Merck & Co, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California."

Keywords

The game is changing. There is a new strategy to evaluate Gilead Sciences fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Gilead Sciences are: Sciences, Gilead, Inc, GILD, Buy, share, stock, and the most common words in the summary are: gilead, science, job, stock, inc, company, gild, . One of the sentences in the summary was: Gileades develops and markets therapies to treat life-threatening infectious diseases.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #gilead #science #job #stock #inc #company #gild.